Display options
Cite
Pidro A, Ahmedbegovic-Pjano M, Grisevic S, et al. Epidemiology of Diabetic Retinopathy at Eye Clinic Svjetlost Sarajevo: Two Years Retrospective Single Center Study. Mater Sociomed. 2019;31(4):290-293doi: 10.5455/msm.2019.31.290-293.
Pidro, A., Ahmedbegovic-Pjano, M., Grisevic, S., Sofic-Drino, V., Gabric, K., & Biscevic, A. (2019). Epidemiology of Diabetic Retinopathy at Eye Clinic Svjetlost Sarajevo: Two Years Retrospective Single Center Study. Materia socio-medica, 31(4), 290-293. https://doi.org/10.5455/msm.2019.31.290-293
Pidro, Ajla, et al. "Epidemiology of Diabetic Retinopathy at Eye Clinic Svjetlost Sarajevo: Two Years Retrospective Single Center Study." Materia socio-medica vol. 31,4 (2019): 290-293. doi: https://doi.org/10.5455/msm.2019.31.290-293
Pidro A, Ahmedbegovic-Pjano M, Grisevic S, Sofic-Drino V, Gabric K, Biscevic A. Epidemiology of Diabetic Retinopathy at Eye Clinic Svjetlost Sarajevo: Two Years Retrospective Single Center Study. Mater Sociomed. 2019 Dec;31(4):290-293. doi: 10.5455/msm.2019.31.290-293. PMID: 32082096; PMCID: PMC7007630.
Copy Download .nbib Format: NLM
Share it on

Mater Sociomed. 2019 Dec;31(4):290-293. doi: 10.5455/msm.2019.31.290-293.

Epidemiology of Diabetic Retinopathy at Eye Clinic Svjetlost Sarajevo: Two Years Retrospective Single Center Study.

Materia socio-medica

Ajla Pidro, Melisa Ahmedbegovic-Pjano, Senad Grisevic, Vernesa Sofic-Drino, Kresimir Gabric, Alma Biscevic

Affiliations

  1. Eye Clinic Svjetlost Sarajevo, Sarajevo, Bosnia and Herzegovina.
  2. University Eye Clinic Svjetlost Zagreb, Zagreb, Croatia.

PMID: 32082096 PMCID: PMC7007630 DOI: 10.5455/msm.2019.31.290-293

Abstract

INTRODUCTION: Diabetic retinopathy (DR) is an important cause of blindness, and occurs as a result of long-term accumulated damage to the small blood vessels in the retina. 2.6% of global blindness can be attributed to diabetes. Disease severity was most often classified by the Early Treatment Diabetic Retinopathy Study (ETDRS) classification for DR severity. Patients are usually categorized based on the severity of DR as having mild nonproliferative diabetic retinopathy (NPDR), moderate NPDR, severe NPDR, or proliferative diabetic retinopathy (PDR).

AIM: To evaluate DR status among patients at Eye Clinic Svjetlost Sarajevo , both, type 1 and type 2 DM patients who presented in our clinic at 2 years period - from June 2016 to June 2018. This is single center study.

METHODS: Retrospective analysis of 753 diabetic patients that came for the first check up in our institution during those two years, 363 patients were male and 390 were female. Patients were divided in 3 groups (based on DR changes): a) No changes, b) Nonproliferative DR (with and without Diabetic macular edema-DME), c) Prolipherative DR (with and without DME + Advanced PDR).

RESULTS: There were 35% of patients with no ocular changes, 41.2% had NPDR and 24% had PDR. Prevalence of DR in our study was 65.32%. Distribution of NPDR was 66.27%, and PDR was 33.73%. DME was present in 33.70% cases. In NPDR, DME was presented in 51% of the cases, while in PDR was presented in 49% of the cases. In state of advanced PDR, PDR was presented in 30.52% cases, tractional detachment and haemophtalmus in 50.20% of cases and neovascular glaucoma in 19.28%. Sixty-three patients ended up with vitroretinal surgery (8.4%) while in other studies that number is up to 3%. Out of that number 9 patients were patient with virgin eyes (14.28%). Neovascular glaucoma occurred in 19.28% of diabetics with proliferative retinopathy and 4.60% in all of diabetics.

CONCLUSION: Diabetic retinopathy status of patients presenting at Eye clinic Svjetlost Sarajevo, Bosnia and Herzegovina is quite poor. There is a big need for early DR screening measures, good prevention and management of DR risk factors. Adequate and ON TIME management of DM and its vision threatening complications is of major importance.

© 2019 Ajla Pidro, Melisa Ahmedbegovic-Pjano, Senad Grisevic, Vernesa Sofic-Drino, Kresimir Gabric, Alma Biscevic.

Keywords: Diabetic retinopathy; Early Treatment Diabetic Retinopathy Study; nonproliferative retinopathy; proliferative retinopathy

Conflict of interest statement

There are no conflicts of interest.

References

  1. Can J Ophthalmol. 2010 Feb;45(1):28-32 - PubMed
  2. JAMA. 2010 Aug 11;304(6):649-56 - PubMed
  3. Lancet Glob Health. 2013 Dec;1(6):e339-49 - PubMed
  4. Rev Assoc Med Bras (1992). 2009 May-Jun;55(3):268-73 - PubMed
  5. Graefes Arch Clin Exp Ophthalmol. 2004 Jul;242(7):535-40 - PubMed
  6. Ophthalmology. 1998 Mar;105(3):406-11 - PubMed
  7. Br J Ophthalmol. 2015 Oct;99(10):1328-33 - PubMed
  8. Lancet. 2010 Jun 26;375(9733):2215-22 - PubMed
  9. Ophthalmology. 2008 Nov;115(11):1869-75 - PubMed
  10. Acta Ophthalmol. 2015 Mar;93(2):e140-7 - PubMed
  11. Arch Ophthalmol. 1989 Feb;107(2):237-43 - PubMed
  12. Ophthalmic Epidemiol. 2014 Jun;21(3):169-77 - PubMed
  13. Eye (Lond). 2014 Aug;28(8):986-91 - PubMed
  14. Arch Ophthalmol. 2004 Apr;122(4):546-51 - PubMed
  15. Ophthalmology. 1992 Jan;99(1):58-62 - PubMed
  16. Ophthalmology. 1991 May;98(5 Suppl):823-33 - PubMed
  17. Acta Ophthalmol Scand. 2004 Aug;82(4):443-8 - PubMed
  18. Ethiop Med J. 2013 Apr;51(2):105-13 - PubMed
  19. Br J Ophthalmol. 2012 Sep;96(9):1168-72 - PubMed
  20. Rev Panam Salud Publica. 2011 Nov;30(5):408-14 - PubMed
  21. Br J Ophthalmol. 2006 Nov;90(11):1404-9 - PubMed
  22. Glob Heart. 2016 Sep;11(3):337-342 - PubMed
  23. Clin Exp Ophthalmol. 2014 Dec;42(9):875-82 - PubMed
  24. Invest Ophthalmol Vis Sci. 2013 Oct 17;54(10):6827-33 - PubMed
  25. Aust N Z J Public Health. 2000 Dec;24(6):565-9 - PubMed
  26. Diabetes Care. 2013 Feb;36(2):336-41 - PubMed
  27. Ophthalmology. 2012 Oct;119(10):2119-24 - PubMed
  28. Nepal J Ophthalmol. 2014 Jan;6(11): - PubMed
  29. Acta Ophthalmol (Copenh). 1983 Aug;61(4):662-72 - PubMed
  30. Ophthalmic Epidemiol. 2010 Aug;17(4):251-65 - PubMed
  31. Arch Ophthalmol. 2004 Apr;122(4):552-63 - PubMed
  32. Acta Ophthalmol. 2013 Dec;91(8):716-21 - PubMed
  33. J Diabetes. 2015 Jan;7(1):139-41 - PubMed
  34. Eye (Lond). 2002 Mar;16(2):140-5 - PubMed
  35. Ophthalmology. 2009 Feb;116(2):311-8 - PubMed
  36. Diabetes Res Clin Pract. 2012 Nov;98(2):329-37 - PubMed
  37. Lancet. 2010 Jul 10;376(9735):124-36 - PubMed
  38. Diabetes Res Clin Pract. 2002 Aug;57(2):119-29 - PubMed

Publication Types